glp-1 intracranial hypertension Effect of glucagon like peptide-1 receptor agonist exenatide, used as an pressure lowering agent, on cognition in Idiopathic Intracranial Efficacy of glucagon-like peptide-1 receptor

Rapid weight loss has consequences for your skin, your hair, your energy levels, and your body composition

Current research limitations include the absence of large-scale randomized clinical trials in humans, an still partial understanding of the precise molecular mechanisms, and a lack of detailed pharmacokinetic data in humans

Chronic inflammation can damage vaginal tissues, reducing elasticity

The company's FAQ states that "PT-141 is FDA-approved for low sexual desire." This requires clarification: bremelanotide (marketed under the brand name Vyleesi) received FDA approval specifically as a subcutaneous injection for hypoactive sexual desire disorder (HSDD) in premenopausal women